Results 141 to 150 of about 1,504,795 (268)
On the distribution of power residues and non-residues.
openaire +2 more sources
Directional Analysis of Residual RPE Area Loss in the Natural History of Choroideremia. [PDF]
Chujo S +14 more
europepmc +1 more source
ABSTRACT Background Japan has one of the highest dialysis prevalence rates worldwide and a shrinking, aging population. Whether dialysis burden has entered a sustained post‐peak phase or whether recent declines partly reflect pandemic‐related disruptions remains uncertain.
Hatice Şahin +2 more
wiley +1 more source
Residual stress modulation as a pathway to reliable multilevel 3D NAND flash storage. [PDF]
Zhou R, Kim IJ, Park S, Kwon H, Lee JS.
europepmc +1 more source
ABSTRACT Introduction Peritoneal dialysis (PD) is an established home‐based kidney replacement therapy (KRT), but its uptake remains low in Japan. We evaluated whether individualized education in a dedicated outpatient clinic was associated with the initiation of PD.
Yasuko Ito +7 more
wiley +1 more source
Effectiveness of drying in digestive endoscope reprocessing: Systematic review on residual droplets and microorganisms. [PDF]
Han C +5 more
europepmc +1 more source
Early‐Phase Research in Pediatric Neuro‐Oncology
Pediatric Blood &Cancer, EarlyView.
Jonathan Cunningham
wiley +1 more source
Enteropathogenic E. coli (EPEC) infects the human intestinal epithelium, resulting in severe illness and diarrhoea. In this study, we compared the infection of cancer‐derived cell lines with human organoid‐derived models of the small intestine. We observed a delayed in attachment, inflammation and cell death on primary cells, indicating that host ...
Mastura Neyazi +5 more
wiley +1 more source
Mechanistic Characterization and Synergistic Optimization of Residual-Oil Distribution in Low-Permeability Bottom-Water Reservoirs. [PDF]
Zhang Y +9 more
europepmc +1 more source
Organoids in pediatric cancer research
Organoid technology has revolutionized cancer research, yet its application in pediatric oncology remains limited. Recent advances have enabled the development of pediatric tumor organoids, offering new insights into disease biology, treatment response, and interactions with the tumor microenvironment.
Carla Ríos Arceo, Jarno Drost
wiley +1 more source

